Wednesday, 13 April 2016
FDA gives Medtronic's PillCam OK for expanded indication on major risk patients
The FDA has cleared Medtronic's PillCam COLON 2 ingestible capsule for an expanded indication in patients who are at major risks for colonoscopy or moderate sedation.
The device is about the size of a vitamin and is swallowed by the patient without the need of sedation, anaesthesia or radiation.
The new indication allows gastroenterologists to provide their at-risk patients with a non-invasive and radiation-free alternative to traditional colonoscopy.